

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.92727554 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.92727554 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.92727554 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.92727554 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.92727554 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.92727554 |
| 7 | cellular response to interferon-alpha (GO:0035457) | 6.50346544 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 6.49638573 |
| 9 | type I interferon signaling pathway (GO:0060337) | 6.37076408 |
| 10 | cellular response to type I interferon (GO:0071357) | 6.37076408 |
| 11 | response to type I interferon (GO:0034340) | 6.31745238 |
| 12 | regulation of interferon-alpha production (GO:0032647) | 6.16107636 |
| 13 | response to interferon-alpha (GO:0035455) | 6.06788208 |
| 14 | response to peptidoglycan (GO:0032494) | 5.46440038 |
| 15 | cellular response to exogenous dsRNA (GO:0071360) | 5.42126986 |
| 16 | response to host immune response (GO:0052572) | 5.05774375 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.05774375 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01589730 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.76977122 |
| 20 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.75100636 |
| 21 | positive regulation of interferon-beta production (GO:0032728) | 4.66752769 |
| 22 | cellular response to interferon-beta (GO:0035458) | 4.63798399 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 4.63761185 |
| 24 | * negative regulation of viral genome replication (GO:0045071) | 4.62124799 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.61582237 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.57958103 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.56409651 |
| 28 | cellular response to virus (GO:0098586) | 4.49409534 |
| 29 | response to host defenses (GO:0052200) | 4.48031340 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.48031340 |
| 31 | response to host (GO:0075136) | 4.48031340 |
| 32 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.41512117 |
| 33 | natural killer cell mediated immunity (GO:0002228) | 4.40804692 |
| 34 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.40804692 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.38703454 |
| 36 | T cell migration (GO:0072678) | 4.37807381 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 4.32976122 |
| 38 | lymphocyte chemotaxis (GO:0048247) | 4.28987070 |
| 39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17631528 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.13768808 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.13768808 |
| 42 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.13386481 |
| 43 | microglial cell activation (GO:0001774) | 4.10962250 |
| 44 | response to interferon-beta (GO:0035456) | 4.09054795 |
| 45 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.06475935 |
| 46 | regulation of chronic inflammatory response (GO:0002676) | 4.05496228 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.04626744 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.01991297 |
| 49 | positive regulation of heat generation (GO:0031652) | 4.01756776 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.99219451 |
| 51 | regulation of RIG-I signaling pathway (GO:0039535) | 3.98212534 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.96611909 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.95201036 |
| 54 | regulation of fever generation (GO:0031620) | 3.89377616 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82400157 |
| 56 | regulation of chemokine biosynthetic process (GO:0045073) | 3.82032811 |
| 57 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.79127620 |
| 58 | negative regulation of cell killing (GO:0031342) | 3.74699959 |
| 59 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.74699959 |
| 60 | respiratory burst (GO:0045730) | 3.69844479 |
| 61 | granulocyte activation (GO:0036230) | 3.68833495 |
| 62 | * regulation of viral genome replication (GO:0045069) | 3.66222813 |
| 63 | * defense response to virus (GO:0051607) | 3.64907592 |
| 64 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.60777609 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.57740995 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.57642299 |
| 67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.56296597 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.51484998 |
| 69 | cellular response to interferon-gamma (GO:0071346) | 3.47321995 |
| 70 | reactive oxygen species biosynthetic process (GO:1903409) | 3.47243637 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.43919321 |
| 72 | defense response to protozoan (GO:0042832) | 3.42734894 |
| 73 | * positive regulation of type 2 immune response (GO:0002830) | 3.41142612 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 3.40710816 |
| 75 | positive regulation of interleukin-12 production (GO:0032735) | 3.39117131 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 3.38144255 |
| 77 | positive regulation of defense response to virus by host (GO:0002230) | 3.36845623 |
| 78 | T-helper 1 type immune response (GO:0042088) | 3.36284727 |
| 79 | regulation of interferon-beta production (GO:0032648) | 3.34853865 |
| 80 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.33293327 |
| 81 | positive regulation of interleukin-17 production (GO:0032740) | 3.31957794 |
| 82 | positive regulation of lymphocyte migration (GO:2000403) | 3.30556546 |
| 83 | I-kappaB phosphorylation (GO:0007252) | 3.30100425 |
| 84 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.29900826 |
| 85 | superoxide anion generation (GO:0042554) | 3.27899722 |
| 86 | detection of other organism (GO:0098543) | 3.25740286 |
| 87 | neutrophil activation (GO:0042119) | 3.24907125 |
| 88 | macrophage activation (GO:0042116) | 3.23587143 |
| 89 | response to protozoan (GO:0001562) | 3.23128640 |
| 90 | regulation of interleukin-12 production (GO:0032655) | 3.22819103 |
| 91 | monocyte chemotaxis (GO:0002548) | 3.22697190 |
| 92 | myeloid dendritic cell differentiation (GO:0043011) | 3.22248467 |
| 93 | B cell mediated immunity (GO:0019724) | 3.21658476 |
| 94 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.19766204 |
| 95 | eosinophil chemotaxis (GO:0048245) | 3.19551590 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18849645 |
| 97 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.17999609 |
| 98 | * regulation of type 2 immune response (GO:0002828) | 3.16873360 |
| 99 | regulation of tolerance induction (GO:0002643) | 3.15556779 |
| 100 | response to exogenous dsRNA (GO:0043330) | 3.14405141 |
| 101 | natural killer cell activation involved in immune response (GO:0002323) | 3.13867894 |
| 102 | regulation of defense response to virus by host (GO:0050691) | 3.12408185 |
| 103 | NIK/NF-kappaB signaling (GO:0038061) | 3.11850583 |
| 104 | response to interferon-gamma (GO:0034341) | 3.10972846 |
| 105 | regulation of interleukin-17 production (GO:0032660) | 3.09606760 |
| 106 | regulation of vitamin metabolic process (GO:0030656) | 3.07804136 |
| 107 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.07535017 |
| 108 | cellular response to lipopolysaccharide (GO:0071222) | 3.06249181 |
| 109 | positive regulation of response to biotic stimulus (GO:0002833) | 3.05438000 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04708339 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 3.04511159 |
| 112 | negative regulation of type I interferon production (GO:0032480) | 3.04393505 |
| 113 | detection of external biotic stimulus (GO:0098581) | 3.03903369 |
| 114 | regulation of podosome assembly (GO:0071801) | 3.03674607 |
| 115 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02384996 |
| 116 | leukocyte mediated cytotoxicity (GO:0001909) | 3.02155064 |
| 117 | detection of molecule of bacterial origin (GO:0032490) | 3.01632321 |
| 118 | regulation of T-helper cell differentiation (GO:0045622) | 3.01551747 |
| 119 | germinal center formation (GO:0002467) | 3.01293395 |
| 120 | cellular response to molecule of bacterial origin (GO:0071219) | 3.01247542 |
| 121 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.00782697 |
| 122 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.00731582 |
| 123 | positive regulation of chemokine production (GO:0032722) | 2.99809487 |
| 124 | regulation of heat generation (GO:0031650) | 2.99529695 |
| 125 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99383038 |
| 126 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99233706 |
| 127 | detection of bacterium (GO:0016045) | 2.98833947 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96420594 |
| 129 | negative regulation of type 2 immune response (GO:0002829) | 2.96132354 |
| 130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95979886 |
| 131 | negative regulation of interleukin-17 production (GO:0032700) | 2.95361879 |
| 132 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.91722044 |
| 133 | * negative regulation of viral process (GO:0048525) | 2.91416871 |
| 134 | interferon-gamma secretion (GO:0072643) | 2.90922733 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90903474 |
| 136 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.90864044 |
| 137 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.90214723 |
| 138 | regulation of immunoglobulin secretion (GO:0051023) | 2.89737724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.28486826 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 8.02937332 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 7.57911549 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.58990148 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.34141776 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.53265346 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.84451873 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.73830636 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.68731343 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.32847764 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.11516199 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.91466385 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80136250 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54485394 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39194916 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.32959934 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.31788589 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.27423096 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.19170917 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90159652 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65989479 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62004192 |
| 23 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.56364973 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55197107 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53388879 |
| 26 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50311953 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46920517 |
| 28 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45766035 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40442799 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39600507 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37621200 |
| 32 | * MYB_26560356_Chip-Seq_TH2_Human | 1.35054466 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28047273 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27640858 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27479105 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26958748 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24490827 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.19512531 |
| 39 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18666945 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18167086 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17451280 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16003583 |
| 43 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14659122 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.13328231 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11046463 |
| 46 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10416135 |
| 47 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09967695 |
| 48 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09626685 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08219187 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07353793 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06654989 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06297686 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06150608 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03646318 |
| 55 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03214322 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02066828 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.02061752 |
| 58 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.97319209 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96777376 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95815269 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95599754 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93652100 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93360415 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93282547 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89203850 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89203850 |
| 67 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88877780 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88835779 |
| 69 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88284142 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85552462 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84984421 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84902244 |
| 73 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84222100 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.81633273 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.78920031 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77181492 |
| 77 | * GATA1_22025678_ChIP-Seq_K562_Human | 0.74576106 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74044437 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.70689787 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.70604129 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70580712 |
| 82 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69911847 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69496790 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69324682 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.67267883 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65478346 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.65418244 |
| 88 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.65165526 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65163700 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 0.62878871 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.62603534 |
| 92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62280701 |
| 93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62194101 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61198863 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60584843 |
| 96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.60212875 |
| 97 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.59977033 |
| 98 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59009662 |
| 99 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.58981033 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.57922289 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57855046 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.56896078 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.56893485 |
| 104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.56514444 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.56471749 |
| 106 | MAF_26560356_Chip-Seq_TH2_Human | 0.55406799 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55340397 |
| 108 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.53899995 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.53177429 |
| 110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.52548774 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.52548774 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.52097814 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.51481911 |
| 114 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.51014516 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.50802147 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50766568 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50526946 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.50437784 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.49976959 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49675229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.60276556 |
| 2 | MP0006082_CNS_inflammation | 4.25670564 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.21998348 |
| 4 | MP0003724_increased_susceptibility_to | 4.06168791 |
| 5 | MP0003303_peritoneal_inflammation | 3.89269665 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.74527989 |
| 7 | MP0003436_decreased_susceptibility_to | 3.68213109 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.29643290 |
| 9 | MP0005025_abnormal_response_to | 3.23113352 |
| 10 | MP0004510_myositis | 3.19870752 |
| 11 | MP0005387_immune_system_phenotype | 3.06321826 |
| 12 | MP0001790_abnormal_immune_system | 3.06321826 |
| 13 | MP0002419_abnormal_innate_immunity | 2.99654075 |
| 14 | MP0000685_abnormal_immune_system | 2.69379428 |
| 15 | MP0005671_abnormal_response_to | 2.57235151 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.48890156 |
| 17 | * MP0002723_abnormal_immune_serum | 2.48741528 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.41210371 |
| 19 | * MP0001800_abnormal_humoral_immune | 2.39970815 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.35810871 |
| 21 | MP0009764_decreased_sensitivity_to | 2.34228704 |
| 22 | MP0004947_skin_inflammation | 2.22594802 |
| 23 | * MP0001819_abnormal_immune_cell | 2.05448285 |
| 24 | MP0003075_altered_response_to | 1.99801651 |
| 25 | MP0003448_altered_tumor_morphology | 1.97689528 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 1.96758764 |
| 27 | MP0005451_abnormal_body_composition | 1.92623295 |
| 28 | MP0008469_abnormal_protein_level | 1.90925085 |
| 29 | MP0004858_abnormal_nervous_system | 1.89710925 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.87081192 |
| 31 | MP0001853_heart_inflammation | 1.86937658 |
| 32 | MP0009278_abnormal_bone_marrow | 1.85852754 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.83760282 |
| 34 | MP0000604_amyloidosis | 1.76082069 |
| 35 | MP0002006_tumorigenesis | 1.71873758 |
| 36 | MP0000343_altered_response_to | 1.69543631 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.68777647 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.64797090 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.61069123 |
| 40 | MP0005164_abnormal_response_to | 1.52852424 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.44189754 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.44030694 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.44030694 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.43742795 |
| 45 | MP0009840_abnormal_foam_cell | 1.41611283 |
| 46 | * MP0000716_abnormal_immune_system | 1.40909390 |
| 47 | MP0002405_respiratory_system_inflammati | 1.40302240 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.40154367 |
| 49 | MP0010307_abnormal_tumor_latency | 1.37701322 |
| 50 | MP0005166_decreased_susceptibility_to | 1.35911354 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.34986403 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.34801189 |
| 53 | MP0006054_spinal_hemorrhage | 1.32705003 |
| 54 | MP0003690_abnormal_glial_cell | 1.29438932 |
| 55 | * MP0002398_abnormal_bone_marrow | 1.26712596 |
| 56 | MP0000858_altered_metastatic_potential | 1.24623925 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.22987963 |
| 58 | MP0003186_abnormal_redox_activity | 1.22055052 |
| 59 | MP0005310_abnormal_salivary_gland | 1.18909499 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.16337491 |
| 61 | MP0009763_increased_sensitivity_to | 1.14138427 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.08722574 |
| 63 | * MP0002429_abnormal_blood_cell | 1.08545921 |
| 64 | MP0005390_skeleton_phenotype | 1.06636903 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.06401834 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.01557797 |
| 67 | MP0000689_abnormal_spleen_morphology | 0.98796148 |
| 68 | MP0003195_calcinosis | 0.95710425 |
| 69 | MP0001501_abnormal_sleep_pattern | 0.90969764 |
| 70 | MP0002722_abnormal_immune_system | 0.90092850 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.87809228 |
| 72 | MP0003045_fibrosis | 0.86626145 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.86051175 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.81701824 |
| 75 | MP0003091_abnormal_cell_migration | 0.80917794 |
| 76 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78489171 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 0.78236307 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.77195557 |
| 79 | MP0008260_abnormal_autophagy | 0.77172123 |
| 80 | MP0001851_eye_inflammation | 0.74941785 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.73947339 |
| 82 | MP0001542_abnormal_bone_strength | 0.73457260 |
| 83 | MP0008874_decreased_physiological_sensi | 0.73037511 |
| 84 | MP0001663_abnormal_digestive_system | 0.72199136 |
| 85 | MP0003646_muscle_fatigue | 0.71595345 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.71506524 |
| 87 | MP0008004_abnormal_stomach_pH | 0.70681824 |
| 88 | MP0000249_abnormal_blood_vessel | 0.69997339 |
| 89 | MP0005083_abnormal_biliary_tract | 0.68281688 |
| 90 | MP0002254_reproductive_system_inflammat | 0.67120730 |
| 91 | MP0003866_abnormal_defecation | 0.65849839 |
| 92 | MP0003329_amyloid_beta_deposits | 0.65349027 |
| 93 | MP0003828_pulmonary_edema | 0.64346702 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.63902355 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.62258394 |
| 96 | MP0005023_abnormal_wound_healing | 0.61667517 |
| 97 | MP0002933_joint_inflammation | 0.60050700 |
| 98 | MP0005165_increased_susceptibility_to | 0.58821215 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.57988317 |
| 100 | MP0001881_abnormal_mammary_gland | 0.57873851 |
| 101 | MP0000703_abnormal_thymus_morphology | 0.57866915 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.57265124 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.56441283 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.56178038 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.53864861 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.53194057 |
| 107 | MP0003795_abnormal_bone_structure | 0.51676815 |
| 108 | MP0000920_abnormal_myelination | 0.50893875 |
| 109 | MP0001958_emphysema | 0.48902898 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.48773451 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.47374526 |
| 112 | MP0004883_abnormal_blood_vessel | 0.46773313 |
| 113 | MP0005535_abnormal_body_temperature | 0.45931248 |
| 114 | MP0000371_diluted_coat_color | 0.45824088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.02266738 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.80892227 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.61116955 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 6.00193815 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.95852085 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.35833989 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.29855794 |
| 8 | Increased IgM level (HP:0003496) | 5.09678745 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.98062633 |
| 10 | Basal ganglia calcification (HP:0002135) | 4.55407130 |
| 11 | Stomatitis (HP:0010280) | 4.44018996 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.22924648 |
| 13 | Prostate neoplasm (HP:0100787) | 4.15179754 |
| 14 | Keratoconjunctivitis (HP:0001096) | 4.13101528 |
| 15 | Vasculitis (HP:0002633) | 4.07122781 |
| 16 | Recurrent skin infections (HP:0001581) | 4.06074327 |
| 17 | Tetraparesis (HP:0002273) | 4.00762649 |
| 18 | Gingivitis (HP:0000230) | 3.98189874 |
| 19 | Chronic otitis media (HP:0000389) | 3.91366080 |
| 20 | Orchitis (HP:0100796) | 3.83269380 |
| 21 | Recurrent viral infections (HP:0004429) | 3.74893839 |
| 22 | Porencephaly (HP:0002132) | 3.72172428 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.70287002 |
| 24 | Myositis (HP:0100614) | 3.64829309 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.62675794 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.59010798 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 3.56446867 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.55342898 |
| 29 | Optic neuritis (HP:0100653) | 3.55342898 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.46922139 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 3.45058231 |
| 32 | T lymphocytopenia (HP:0005403) | 3.37092774 |
| 33 | Abnormality of T cell number (HP:0011839) | 3.31745870 |
| 34 | Obstructive lung disease (HP:0006536) | 3.27965668 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.27965668 |
| 36 | Thick nail (HP:0001805) | 3.23024719 |
| 37 | Periodontitis (HP:0000704) | 3.13082819 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 3.02603562 |
| 39 | Gangrene (HP:0100758) | 3.00997058 |
| 40 | Encephalitis (HP:0002383) | 2.99516325 |
| 41 | Pustule (HP:0200039) | 2.99184467 |
| 42 | Axonal loss (HP:0003447) | 2.83787423 |
| 43 | Nasal polyposis (HP:0100582) | 2.82083282 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.81827584 |
| 45 | Urticaria (HP:0001025) | 2.81378846 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.80583183 |
| 47 | Premature loss of primary teeth (HP:0006323) | 2.79679598 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.77163998 |
| 49 | Cellulitis (HP:0100658) | 2.74585072 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.71788174 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.71788174 |
| 52 | Cleft eyelid (HP:0000625) | 2.66678387 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62473244 |
| 54 | Disinhibition (HP:0000734) | 2.58019252 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.57621675 |
| 56 | Recurrent pneumonia (HP:0006532) | 2.57272285 |
| 57 | Poor head control (HP:0002421) | 2.54850331 |
| 58 | Neoplasm of head and neck (HP:0012288) | 2.53865663 |
| 59 | Esophageal neoplasm (HP:0100751) | 2.53865663 |
| 60 | Polyneuropathy (HP:0001271) | 2.46264596 |
| 61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44869010 |
| 62 | Abnormality of the endocardium (HP:0004306) | 2.44718047 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40595846 |
| 64 | Hepatosplenomegaly (HP:0001433) | 2.39812269 |
| 65 | Osteomyelitis (HP:0002754) | 2.39259186 |
| 66 | Increased IgE level (HP:0003212) | 2.39092592 |
| 67 | Abnormality of B cell number (HP:0010975) | 2.38273441 |
| 68 | Episodic fever (HP:0001954) | 2.38220392 |
| 69 | Pulmonary embolism (HP:0002204) | 2.38022292 |
| 70 | Osteolytic defects of the hand bones (HP:0009699) | 2.37906227 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37906227 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.37705680 |
| 73 | Gingival bleeding (HP:0000225) | 2.37575359 |
| 74 | Hematochezia (HP:0002573) | 2.35219188 |
| 75 | Amyloidosis (HP:0011034) | 2.34803576 |
| 76 | Myocardial infarction (HP:0001658) | 2.34766484 |
| 77 | Leukocytosis (HP:0001974) | 2.34410504 |
| 78 | Progressive neurologic deterioration (HP:0002344) | 2.33263449 |
| 79 | Lower limb hyperreflexia (HP:0002395) | 2.32850289 |
| 80 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32397166 |
| 81 | Chronic sinusitis (HP:0011109) | 2.32203238 |
| 82 | Vertigo (HP:0002321) | 2.32090841 |
| 83 | Recurrent bronchitis (HP:0002837) | 2.32054240 |
| 84 | Plagiocephaly (HP:0001357) | 2.30696403 |
| 85 | Glomerulonephritis (HP:0000099) | 2.29972371 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.29782790 |
| 87 | Bone pain (HP:0002653) | 2.29603305 |
| 88 | Joint swelling (HP:0001386) | 2.27589541 |
| 89 | Abnormality of the pericardium (HP:0001697) | 2.26905255 |
| 90 | Purpura (HP:0000979) | 2.24816014 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24564617 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24564617 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24564617 |
| 94 | Nephritis (HP:0000123) | 2.24502036 |
| 95 | Petechiae (HP:0000967) | 2.24421264 |
| 96 | Hemoptysis (HP:0002105) | 2.23940429 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.21574116 |
| 98 | Keratitis (HP:0000491) | 2.20098944 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19749088 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19749088 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19749088 |
| 102 | Loss of speech (HP:0002371) | 2.17849589 |
| 103 | Glomerulopathy (HP:0100820) | 2.17319614 |
| 104 | Spastic tetraparesis (HP:0001285) | 2.17256210 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.16092775 |
| 106 | Acne (HP:0001061) | 2.16044891 |
| 107 | Progressive visual loss (HP:0000529) | 2.15766858 |
| 108 | Arterial thrombosis (HP:0004420) | 2.13602776 |
| 109 | Meningitis (HP:0001287) | 2.12937567 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11415114 |
| 111 | Mucopolysacchariduria (HP:0008155) | 2.11415114 |
| 112 | Anorexia (HP:0002039) | 2.11127754 |
| 113 | Pathologic fracture (HP:0002756) | 2.08933826 |
| 114 | Increased serum ferritin (HP:0003281) | 2.08896712 |
| 115 | B lymphocytopenia (HP:0010976) | 2.07796010 |
| 116 | Chest pain (HP:0100749) | 2.07338055 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 2.07320571 |
| 118 | Abnormality of T cells (HP:0002843) | 2.06239237 |
| 119 | Mutism (HP:0002300) | 2.05032913 |
| 120 | Abnormality of the basal ganglia (HP:0002134) | 2.04120396 |
| 121 | Hemorrhage of the eye (HP:0011885) | 2.03348365 |
| 122 | Cheilitis (HP:0100825) | 2.01746548 |
| 123 | Spontaneous hematomas (HP:0007420) | 2.01690475 |
| 124 | Nausea (HP:0002018) | 2.00814523 |
| 125 | Eosinophilia (HP:0001880) | 1.99610048 |
| 126 | Neurofibrillary tangles (HP:0002185) | 1.98529402 |
| 127 | Skin ulcer (HP:0200042) | 1.98270125 |
| 128 | Arthralgia (HP:0002829) | 1.96578137 |
| 129 | Parakeratosis (HP:0001036) | 1.95964139 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.95606944 |
| 131 | Abnormality of the pleura (HP:0002103) | 1.95215833 |
| 132 | Memory impairment (HP:0002354) | 1.91635808 |
| 133 | Peritonitis (HP:0002586) | 1.90820606 |
| 134 | IgA deficiency (HP:0002720) | 1.88866824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.15163072 |
| 2 | MAP3K14 | 4.25844949 |
| 3 | TYK2 | 4.20459903 |
| 4 | TBK1 | 4.12258351 |
| 5 | IKBKE | 3.77887222 |
| 6 | RIPK4 | 3.49862710 |
| 7 | IRAK4 | 3.25272051 |
| 8 | JAK1 | 2.76309728 |
| 9 | JAK3 | 2.73572379 |
| 10 | BLK | 2.68766344 |
| 11 | PIM2 | 2.68627923 |
| 12 | IRAK3 | 2.62793278 |
| 13 | MAP3K13 | 2.29423081 |
| 14 | KIT | 2.25401228 |
| 15 | IKBKB | 2.16910100 |
| 16 | PRPF4B | 2.10328760 |
| 17 | TAOK2 | 2.05328173 |
| 18 | ERN1 | 1.95264938 |
| 19 | FGFR4 | 1.94031485 |
| 20 | TXK | 1.72430539 |
| 21 | DDR2 | 1.66960880 |
| 22 | MAP2K3 | 1.66419116 |
| 23 | TAOK1 | 1.64232134 |
| 24 | ARAF | 1.57169539 |
| 25 | MAP3K3 | 1.54626222 |
| 26 | MAP3K5 | 1.54224317 |
| 27 | CSK | 1.54135116 |
| 28 | MAP4K1 | 1.42232415 |
| 29 | IRAK1 | 1.39520976 |
| 30 | MATK | 1.35972945 |
| 31 | CHUK | 1.35529452 |
| 32 | BMX | 1.27387271 |
| 33 | FGFR3 | 1.24003442 |
| 34 | EPHA3 | 1.20121615 |
| 35 | CDC42BPA | 1.18641282 |
| 36 | SYK | 1.16863050 |
| 37 | FGR | 1.16816884 |
| 38 | EPHB1 | 1.16637385 |
| 39 | STK4 | 1.16479645 |
| 40 | IRAK2 | 1.15990753 |
| 41 | BMPR2 | 1.15642217 |
| 42 | TAOK3 | 1.12016443 |
| 43 | EIF2AK2 | 1.11733005 |
| 44 | HCK | 1.09196555 |
| 45 | ABL2 | 1.05841348 |
| 46 | MST4 | 1.04211221 |
| 47 | ZAP70 | 1.02908861 |
| 48 | RPS6KA4 | 1.02340600 |
| 49 | JAK2 | 0.98120701 |
| 50 | MARK3 | 0.95764145 |
| 51 | LYN | 0.95182792 |
| 52 | NEK9 | 0.94278416 |
| 53 | PIM1 | 0.93754276 |
| 54 | MST1R | 0.90693884 |
| 55 | LCK | 0.90292576 |
| 56 | TNK2 | 0.86526862 |
| 57 | HIPK2 | 0.79298376 |
| 58 | NME2 | 0.71631634 |
| 59 | ACVR1B | 0.69094931 |
| 60 | EGFR | 0.60804617 |
| 61 | TYRO3 | 0.60402680 |
| 62 | MAP2K6 | 0.58758659 |
| 63 | DAPK3 | 0.58533009 |
| 64 | DYRK3 | 0.57982444 |
| 65 | FES | 0.57258939 |
| 66 | SIK3 | 0.57102081 |
| 67 | PRKCD | 0.56980510 |
| 68 | ABL1 | 0.56878714 |
| 69 | CLK1 | 0.55180271 |
| 70 | PLK2 | 0.54351236 |
| 71 | STK3 | 0.52738586 |
| 72 | MAP3K9 | 0.51213176 |
| 73 | GRK7 | 0.50538378 |
| 74 | ITK | 0.48891891 |
| 75 | PRKCQ | 0.47291907 |
| 76 | MOS | 0.46787961 |
| 77 | CSF1R | 0.46352074 |
| 78 | YES1 | 0.46023885 |
| 79 | RPS6KA5 | 0.43107847 |
| 80 | MAPK7 | 0.42808728 |
| 81 | KSR2 | 0.41590143 |
| 82 | STK10 | 0.40795978 |
| 83 | BTK | 0.40533599 |
| 84 | MAP3K1 | 0.38688393 |
| 85 | DAPK2 | 0.36189151 |
| 86 | TRPM7 | 0.34178601 |
| 87 | NLK | 0.34039330 |
| 88 | ERBB3 | 0.31801581 |
| 89 | ERBB4 | 0.31241746 |
| 90 | SIK2 | 0.30915468 |
| 91 | MAP3K10 | 0.30903617 |
| 92 | MAP3K6 | 0.30385769 |
| 93 | ADRBK2 | 0.30317307 |
| 94 | FYN | 0.28236797 |
| 95 | GRK6 | 0.27698546 |
| 96 | PRKD2 | 0.27686996 |
| 97 | RIPK1 | 0.27578504 |
| 98 | MARK2 | 0.27008864 |
| 99 | CDK6 | 0.25633364 |
| 100 | DYRK1B | 0.24756099 |
| 101 | PDPK1 | 0.23760920 |
| 102 | MAPK11 | 0.23323361 |
| 103 | TEC | 0.22961481 |
| 104 | ALK | 0.22685131 |
| 105 | CDK4 | 0.22488781 |
| 106 | PKN1 | 0.21882336 |
| 107 | PDGFRB | 0.21331654 |
| 108 | PLK4 | 0.21331058 |
| 109 | CAMKK2 | 0.21113880 |
| 110 | MAP3K11 | 0.18514031 |
| 111 | BMPR1B | 0.17405409 |
| 112 | SGK1 | 0.16942078 |
| 113 | MAPK4 | 0.16830858 |
| 114 | TESK2 | 0.16231247 |
| 115 | MAPKAPK2 | 0.15380211 |
| 116 | PDK1 | 0.15318333 |
| 117 | CAMK1D | 0.14210632 |
| 118 | MAPK3 | 0.14171283 |
| 119 | IGF1R | 0.13804469 |
| 120 | SRC | 0.13095752 |
| 121 | INSR | 0.12976703 |
| 122 | TGFBR2 | 0.12777010 |
| 123 | RPS6KA6 | 0.12441529 |
| 124 | PRKCE | 0.12220450 |
| 125 | PRKG2 | 0.11726504 |
| 126 | TESK1 | 0.10491871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.60285028 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.59598223 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.31889893 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.31469720 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 3.20438594 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98630514 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.87406596 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.67427386 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.56494230 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.43301369 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.42478120 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.41908381 |
| 13 | * Influenza A_Homo sapiens_hsa05164 | 2.41876713 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 2.35288236 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.25804171 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.22648768 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.20285193 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10193164 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09768734 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.08712251 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08181273 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 2.05227386 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.00865133 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97254030 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.71974355 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61517578 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59039208 |
| 28 | Hepatitis C_Homo sapiens_hsa05160 | 1.56446059 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45032416 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38531366 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.34020861 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33383107 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28444337 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.25924545 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.24834508 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.21187220 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14488332 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13451355 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12870904 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08953945 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08054184 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.07697004 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07597390 |
| 44 | Prion diseases_Homo sapiens_hsa05020 | 0.95392697 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92363979 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 0.90119842 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89154641 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86466160 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83790637 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81586036 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70158508 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66701692 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63209890 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61829456 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.57773652 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54203866 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52451612 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50934900 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50866182 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50374387 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.49804492 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48503575 |
| 63 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47844577 |
| 64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47486047 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46987078 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46366924 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43388858 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43232265 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41235175 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40611081 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39557645 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38865520 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35841405 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35605768 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34923152 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34898097 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34733085 |
| 78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34258297 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33880165 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.32918077 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30952134 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29438595 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28516360 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24541390 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.20386042 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19735081 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19055320 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18672794 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.18664477 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.18433996 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.17844792 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17056988 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16802950 |
| 94 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.16772953 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16053895 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15509844 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.15452797 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14826941 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14346500 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13374138 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10957534 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.10941637 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09593499 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08920835 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08836377 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07060180 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06520073 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.06437636 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.06315890 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.04912952 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03513901 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03491409 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.00947473 |

